Gilder Gagnon Howe & Co’s Oak Street Health, Inc. OSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-551,620
Closed -$23.5M 448
2021
Q3
$23.5M Sell
551,620
-748,469
-58% -$40.2M 0.12% 148
2021
Q2
$76.1M Sell
1,300,089
-682,898
-34% -$40.6M 0.37% 72
2021
Q1
$108M Buy
1,982,987
+6,252
+0.3% +$348K 0.58% 52
2020
Q4
$121M Sell
1,976,735
-16,320
-0.8% -$856K 0.6% 52
2020
Q3
$107M Buy
+1,993,055
New +$89.2M 0.66% 49

Other funds holding OSH

Gilder Gagnon Howe & Co's OSH Position: Q4 2021 in Review

Gilder Gagnon Howe & Co sold out of Oak Street Health, Inc. (OSH) in Q4 2021, closing a stake of 551,620 shares — an estimated $23.5M sold.

Gilder Gagnon Howe & Co first reported a position in OSH in Q3 2020 and held it in 5 quarters. The position peaked at $121M in Q4 2020. 222 funds tracked by Wall St. Rank hold OSH as of Q4 2021.

  • Gilder Gagnon Howe & Co reported no remaining Oak Street Health, Inc. position as of Q4 2021 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 551,620 Oak Street Health, Inc. shares in Q4 2021, an estimated $23.5M.
  • Gilder Gagnon Howe & Co first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 5 quarters.
  • Gilder Gagnon Howe & Co's Oak Street Health, Inc. position peaked at $121M in Q4 2020.
  • 222 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q4 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2021, filed 14 Feb 2022.